Abata Therapeutics

Associate Director, Device Development

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Position Overview

  • Location Type: Remote
  • Employment Type: Full-time
  • Salary: Not specified

Apogee Therapeutics, Inc. (Ticker: APGE), a Nasdaq listed biotechnology company founded in 2022, is seeking an Associate Director, Device Development to lead the development of biologic/device combination products. This role focuses on prefilled syringes with needle safety devices and autoinjectors, supporting clinical supply, commercial manufacturing, and regulatory submissions. The company is committed to building an exceptional culture based on its C.O.R.E. values: Caring, Original, Resilient, and Egoless.

Requirements

  • Technical leadership experience in biologic/device combination product development.
  • Subject matter expertise (SME) in product design and development, technology transfer, and cGMP manufacturing oversight.
  • Experience working with external suppliers, manufacturers, and cross-functional teams.
  • Ability to author design control documentation (User Requirements Specifications, Design Input Requirements, Design Verification plans, protocols, and reports).
  • Knowledge of quality management systems.

Responsibilities

  • Provide technical leadership on cross-functional teams for combination product development.
  • Collaborate with the Quality function to develop and refine the combination product quality management system.
  • Author product-specific design control documentation.
  • Oversee test method development, validation, and design verification at external labs.
  • Establish human factors strategies and work with human factors service vendors to execute formative and summative HF studies.
  • Work with contract manufacturing organizations (CMOs) and contract research organizations (CROs) to ensure product development milestones are met.

Company Information

Apogee Therapeutics, Inc. is a biotechnology company focused on developing differentiated biologics for atopic dermatitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications. The company’s antibody programs aim to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering. They are committed to reshaping the standard of care for inflammatory and immune diseases.

Application Instructions

  • Not specified in the provided job description.

Skills

Biologic/device combination product development
Product design and development
Technology transfer
cGMP manufacturing oversight
Design control documentation
Test method development and validation
Design verification
Human factors strategies
Quality management systems

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI